Blood Cancer
EAA242
Phase Ib/II Fixed Duration Study of Teclistamab/Pomalidomide (TP) versus Carfilzomib/Pomalidomide/Dexamethasone (KPd) in Early Relapse of Multiple Myeloma
Physician and Research Staff Educational Material
This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.
Physician Fact Sheet
